Pandemic Timeline

SARS-CoV-2 Timeline

SARS-CoV-2 Timeline

December 9 2019

Peter Daszak, the “Principal Investigator”

Peter Daszak is listed as the “Principal Investigator” on the grant from Fauci’s agency to the Wuhan Institute. Dazak’s EcoHealth Alliance has received $3.7 million for bat coronavirus experiments and given over half a million of that funding to the Wuhan Institute of Virology to conduct testing and lab analysis of bat samples, federal records show.

January 23 2020

Quarantine of Wuhan China

On the first full day China quarantined the city of Wuhan, newly released emails from Judicial Watch show Fauci immediately wanted to know about NIH funding to the Wuhan lab.

January 27 2020

Tony knows but…

Daszak emailed Fauci’s staff and told them to “pass on to Tony” the information that “the Wuhan Institute” is “currently working on the nCoV,” or a novel coronavirus, and that they had previously “[f]ound SARS-related CoVs that can bind to human cells[.]”

Fauci publicly opposed travel restrictions on China saying: “That would create a lot of disruption economically and otherwise and it wouldn’t necessarily have a positive effect.”

January 31 2020

Features (potentially) look engineered…

On January 31, 2020, at 10:32 p.m., Dr. Fauci received an email from British researcher, Dr. Kristian Andersen.

One has to look really closely at all the sequences to see that some of the features (potentially) look engineered . . . Eddie [Holmes], Bob [Garry], Mike [Ferguson] and myself all find the genome inconsistent with evolutionary theory.

31 January 2020, Spain confirmed its first COVID-19 case in La Gomera, Canary Islands.

February 1 2020

Distant ties to gain-of-function?

Fauci Emails: The paper you sent me says the experiments were performed before the gain-of-function pause but have since been reviewed and approved by NIH. Not sure what this means since [we are] sure that no coronavirus work has gone through the P3 framework. [We] will try to determine if we have any distant ties to this work abroad.

February 4 2020

Remdesivir and Chloroquine

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
In Vitro study showing that Remdesivir and CQ potently blocked SARS-CoV-2 infection.
Wang et al., 2/4/2020, peer-reviewed, 10 authors.
https://www.nature.com/articles/s41422-020-0282-0?fbclid=IwAR0sG1G81fFcpaEubHB_oCyNsiVs8_7R1KkwOuqjRhx7psfHV6iSDRD1cM0

February 5 2020

Masks are meant for infected people?

Fauci advised against wearing masks and said that face masks bought in a store would not be effective at protecting against the virus. He was replying to queries from one Sylvia Burwell, who may be to the same Sylvia Burwell who served as secretary for health and human services from 2014 to 2017.
“Masks are really for infected people to prevent them from spreading infection to people who are not infected rather than protecting uninfected people from acquiring infection,” Fauci wrote.
“The typical mask you buy in the drug store is not really effective in keeping out virus, which is small enough to pass through material. It might, however, provide some slight benefit in keep out gross droplets if someone coughs or sneezes on you.”

February 19 2020

Chloroquine phosphate

Breakthrough:Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Results from 15 clinical trials in China showing CQ is effective.
Gao et al., 2/19/2020, peer-reviewed, 3 authors.
https://www.jstage.jst.go.jp/article/bst/14/1/14_2020.01047/_article/-char/en

February 26 2020

First reported case in Andalusia

26 February, the first reported case in Andalusia was confirmed in Seville, the first case of community transmission reported in Spain.[49] The next day, eight cases of Italian origin and one from Iran were reported, in Catalunya, Castile and León, and Valencia.

March 4 2020

Chloroquine and Hydroxychloroquine

March 4 – Chloroquine and Hydroxychloroquine as Available Weapons to Fight COVID-19
Recommending CQ and HCQ for COVID-19 based on 20 clinical studies in China and a strong rationale for use.
Colson et al., 3/4/2020, peer-reviewed, 5 authors.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135139/

March 13 2020

A state of alarm

Prime Minister of Spain Pedro Sánchez announced a declaration of a nationwide State of Alarm for 15 days, to become effective the following day after the approval of the Council of Ministers.

March 17 2020

Alberta State of Emergency

Alberta Premier, Jason Kenney declares a public state of health emergency to combat the arrival of the COVID-19 pandemic. Several restrictions and social distancing rules are introduced, including a ban on organized gatherings of more than 50 people.

March 18 2020

HCQ is effective in vitro

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
In Vitro study showing that HCQ is effective in vitro and less toxic than CQ. In addition to direct antiviral activity, HCQ is a safe and successful anti-inflammatory agent that has been used extensively in autoimmune diseases and can significantly decrease the production of cytokines and, in particular, pro-inflammatory factors. Therefore, in COVID-19 patients, HCQ may also contribute to attenuating the inflammatory response. Careful design of clinical trials is important to achieve efficient and safe control of the infection.
Liu et al., 3/18/2020, peer-reviewed, 10 authors.
https://www.nature.com/articles/s41421-020-0156-0

March 27 2020

500+ cases in Alberta

As the number of cases in Alberta surpasses 500, Kenney introduces more restrictions, limiting outdoor and indoor events to 15 people. Some non-essential businesses are closed.

March 28 2020

Spain bans non-essentials

The Spanish government banned all non-essential activity,[119][120] providing affected workers with paid recoverable leave unless they provide an essential service, work remotely, are on sick leave, or have their contracts suspended.

March 30 2020

FDA Authorizes Hydroxychloroquine

FDA Authorizes Use of Hydroxychloroquine

FDA issues an emergency use authorization (EUA) forhydroxychloroquine sulfate and chloroquine phosphate products” to be donated to the Strategic National Stockpile and donated to hospitals to treat patients with COVID-19. The EUA would be rescinded June 15, except for patients in clinical trials, in the wake of reports of heart rhythm problems among some patients.

April 1 2020

Fauci & Gates

Fauci spoke to Microsoft founder Bill Gates on the phone on April 1, 2020, saying he was “enthusiastic about moving forward on a collaborative and hopefully synergistic approach to COVID-19.”

April 3 2020

Ivermectin: inhibitor of SARS-CoV-2?

In Vitro study showing that ivermectin is an inhibitor of SARS-CoV-2, with a single addition to Vero-hSLAM cells 2h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48h.
Caly et al., 4/3/2020, peer-reviewed, 5 authors.
https://www.sciencedirect.com/science/article/pii/S0166354220302011

April 13 2020

Chloroquine vs. Hydroxychloroquine

April 13 – Update on Use of Chloroquine/Hydroxychloroquine to Treat Coronavirus Disease 2019 (COVID-19)
Increasing evidence from completed clinical studies shows CQ and HCQ effective (HCQ more effective).
Gao et al., 4/13/2020, peer-reviewed, 2 authors.

April 20 2020

Meat processing plant closes down

As the first wave continues to grow, the Cargill meat processing plant in High River, Alta., temporarily closes after the operation is linked to more than 350 cases of COVID-19.